Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04551144 · ClinicalTrials.gov registry record
Effect of Transgender Therapy on Muscle, Fat and Tissue Receptors
A clinical trial, sponsored by St. Louis University.
- Terminated
- Registry status
- 4
- Enrollment target
NCT04551144 is a clinical trial that was terminated before completion, run by St. Louis University. The registered enrollment target is 4 participants.
The verdict
NCT04551144 was terminated before completion, sponsored by St. Louis University.
- TERMINATED
- Registry status
- 4 participants
- Enrollment target
Study Summary
The purpose of this research is to find out if hormone therapy in transgender subjects' changes hormone receptors in blood, muscle and fat; fat production; muscle production; and inflammation processes.
Interventions
- DRUG testosterone cypionate
- DRUG Estradiol Valerate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2020-10-06 |
| Est. Completion | 2023-01-18 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04551144
The ClinicalTrials.gov registry entry for NCT04551144 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is St. Louis University, which has 107 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which testosterone cypionate is the first listed.
NCT04551144 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04551144 about?
NCT04551144 is a clinical study titled "Effect of Transgender Therapy on Muscle, Fat and Tissue Receptors". The purpose of this research is to find out if hormone therapy in transgender subjects' changes hormone receptors in blood, muscle and fat; fat production; muscle production; and inflammation processes.
What is the current status of trial NCT04551144?
This trial is currently terminated. The enrollment target is 4 participants. The study started on 2020-10-06. Estimated completion is 2023-01-18.
What interventions are being tested in trial NCT04551144?
The interventions under investigation include: testosterone cypionate (DRUG), Estradiol Valerate (DRUG).
Who is sponsoring clinical trial NCT04551144?
This trial is sponsored by St. Louis University, which has 107 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.